The ROE as of December 2024 (TTM) for VentriPoint Diagnostics Ltd. (VPTDF) is 388.60%

According to VentriPoint Diagnostics Ltd.’s latest financial reports and current stock price. The company's current ROE is 388.60%. This represents a change of -485.47% compared to the average of -100.81% of the last 4 quarters.

VentriPoint Diagnostics Ltd. (VPTDF) Historical ROE (quarterly & annually)

How has VPTDF ROE performed in the past?

The mean historical ROE of VentriPoint Diagnostics Ltd. over the last ten years is -129.70%. The current 388.60% ROE has changed -399.61% with respect to the historical average. Over the past ten years (40 quarters), VPTDF's ROE was at its highest in in the March 2024 quarter at 128.88%. The ROE was at its lowest in in the December 2023 quarter at -652.12%.

VentriPoint Diagnostics Ltd. (VPTDF) ROE by Quarter and Year

Discovering the peaks and valleys of VentriPoint Diagnostics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

VentriPoint Diagnostics Ltd. (VPTDF) Average ROE

How has VPTDF ROE performed in the past?

The current ROE of VentriPoint Diagnostics Ltd. (VPTDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

VentriPoint Diagnostics Ltd. (VPTDF) ROE vs. Peers

How is VPTDF’s ROE compared to its peers?

VentriPoint Diagnostics Ltd.’s ROE is less than Manhattan Scientifics, Inc. (47.28%), greater than Cannabix Technologies Inc. (-78.37%), less than Accelerate Diagnostics, Inc. (165.71%), less than Venus Concept Inc. (884.09%), greater than NeuroPace, Inc. (-205.41%), greater than Delcath Systems, Inc. (-316.26%), greater than Surmodics, Inc. (-9.56%), less than ProSomnus, Inc. (50.75%), greater than CVRx, Inc. (-89.06%), greater than Integra LifeSciences Holdings Corporation (-0.35%), greater than Monogram Orthopaedics, Inc. (-130.89%), greater than Axonics, Inc. (-0.88%), greater than Nano-X Imaging Ltd. (-27.63%), less than Medtronic plc (8.64%),

Build a custom stock screener for VentriPoint Diagnostics Ltd. (VPTDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VentriPoint Diagnostics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VentriPoint Diagnostics Ltd. (VPTDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VentriPoint Diagnostics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.